ClinicalTrials.Veeva

Menu

PRoMOTE Follow-up Observational Study (PRoMOTE FU)

Medtronic logo

Medtronic

Status

Completed

Conditions

Heart Failure

Treatments

Device: Implantable Cardiac Defibrillator, Cardiac Resynchronization Therapy Defibrillator/Pacemaker

Study type

Observational

Funder types

Industry

Identifiers

NCT03009175
PRoMOTE FU

Details and patient eligibility

About

The purpose of the study is:

  • To evaluate the Heart Failure Risk Status (HFRS) feature performance.
  • To establish the feasibility of remote follow-up in which patient risk triaging is performed by nurse-led review of HFRS feature as supplemental information.

Enrollment

287 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients that meet all of following criteria could be included in the study:

  • Implant of a commercially available Medtronic CRTD or ICD device with or without the Optivol Fluid Status Monitoring feature.
  • Inclusion in the Medtronic Carelink Network.
  • Local consent available for CL network as well as general local consent available for the use of data in observational studies signed and informative sheet delivered.

Exclusion criteria

  • Patients under the age of 18 years.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems